Publications
Targeting cancer stem cells via integrin β4
Dobson, HE,
Ruan, S,
Chang, AE,
Wicha, MS,
Li, Q,
Oncotarget, 2021 Aug; DOI:10.18632/oncotarget.27977 Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Choueiri, TK,
Tomczak, P,
Park, SH,
Venugopal, B,
Ferguson, T,
Chang, Y-H,
Hajek, J,
Symeonides, SN,
Lee, JL,
Sarwar, N,
Thiery-Vuillemin, A,
Gross-Goupil, M,
Mahave, M,
Haas, NB,
Sawrycki, P,
Gurney, H,
Chevreau, C,
Melichar, B,
Kopyltsov, E,
Alva, A,
Burke, JM,
Doshi, G,
Topart, D,
Oudard, S,
Hammers, H,
Kitamura, H,
Bedke, J,
Perini, RF,
Zhang, P,
Imai, K,
Willemann-Rogerio, J,
Quinn, DI,
Powles, T,
KEYNOTE-564 Investigators, Array,
N Engl J Med, 2021 Aug; DOI:10.1056/NEJMoa2106391 Constitutive Hedgehog/GLI2 signaling drives extracutaneous basaloid squamous cell carcinoma development and bone remodeling
Grachtchouk, M,
Liu, J,
Hutchin, ME,
Harms, PW,
Thomas, D,
Wei, L,
Wang, A,
Cummings, D,
Lowe, L,
Garlick, J,
Sciubba, J,
Chinnaiyan, AM,
Verhaegen, ME,
Dlugosz, AA,
Carcinogenesis, 2021 Aug; DOI:10.1093/carcin/bgab050 Imaging of treatment response during systemic therapy for hepatocellular carcinoma
Masch, WR,
Kampalath, R,
Parikh, N,
Shampain, KA,
Aslam, A,
Chernyak, V,
Abdom Radiol (NY), 2021 Aug; DOI:10.1007/s00261-021-03100-0 Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal Cancer
Gharzai, LA,
Burger, N,
Li, P,
Jaworski, EM,
Henderson, C,
Spector, M,
Rosko, A,
Chen, MM,
Prince, ME,
Bradford, CR,
Malloy, KM,
Stucken, CL,
Swiecicki, P,
Worden, F,
Schipper, MJ,
Schonewolf, CA,
Shah, J,
Jagsi, R,
Chinn, S,
Shuman, A,
Casper, K,
Mierzwa, ML,
Oncologist, 2021 Aug; DOI:10.1002/onco.13784 Impact of vestibular nerve preservation on facial and hearing outcomes in small vestibular schwannoma surgery: a technical feasibility study
Labib, MA,
Inoue, M,
Banakis Hartl, RM,
Cass, S,
Gubbels, S,
Lawton, MT,
Youssef, AS,
Acta Neurochir (Wien), 2021 Aug; DOI:10.1007/s00701-020-04678-y Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents
Aslam, A,
Kamath, A,
Spieler, B,
Maschiocchi, M,
Sabottke, CF,
Chernyak, V,
Lewis, SC,
Abdom Radiol (NY), 2021 Aug; DOI:10.1007/s00261-021-03076-x Pembrolizumab in Patients with Metastatic Breast Cancer with High Tumor Mutational Burden: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Alva, AS,
Mangat, PK,
Garrett-Mayer, E,
Halabi, S,
Hansra, D,
Calfa, CJ,
Khalil, MF,
Ahn, ER,
Cannon, TL,
Crilley, P,
Fisher, JG,
Haslem, DS,
Shrestha, S,
Antonelli, KR,
Butler, NL,
Warren, SL,
Rygiel, AL,
Ranasinghe, S,
Bruinooge, SS,
Schilsky, RL,
J Clin Oncol, 2021 Aug; DOI:10.1200/JCO.20.02923 Toll-like receptors, environmental caging, and lung dysbiosis
Lipinski, JH,
Falkowski, NR,
Huffnagle, GB,
Erb-Downward, JR,
Dickson, RP,
Moore, BB,
O'Dwyer, DN,
Am J Physiol Lung Cell Mol Physiol, 2021 Aug; DOI:10.1152/ajplung.00002.2021 Fresh and cryopreserved ovarian tissue from deceased young donors yields viable follicles
Fan, Y,
Flanagan, CL,
Brunette, MA,
Jones, AS,
Baker, BM,
Silber, SJ,
Shikanov, A,
F S Sci, 2021 Aug; DOI:10.1016/j.xfss.2021.06.003 Effect of iodinated contrast material on post-operative eGFR when administered during renal mass ablation
Curci, NE,
Triche, BL,
Abel, EJ,
Bhutani, G,
Maciolek, KA,
Dreyfuss, LD,
Allen, GO,
Caoili, EM,
Davenport, MS,
Wells, SA,
Eur Radiol, 2021 Aug; DOI:10.1007/s00330-020-07613-y SBRT for HCC: Overview of technique and treatment response assessment
Shampain, KL,
Hackett, CE,
Towfighi, S,
Aslam, A,
Masch, WR,
Harris, AC,
Chang, SD,
Khanna, K,
Mendiratta, V,
Gabr, AM,
Owen, D,
Mendiratta-Lala, M,
Abdom Radiol (NY), 2021 Aug; DOI:10.1007/s00261-021-03107-7 TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma.
Wang, X-M,
Zhang, Y,
Mannan, R,
Skala, SL,
Rangaswamy, R,
Chinnaiyan, A,
Su, F,
Cao, X,
Zelenka-Wang, S,
McMurry, L,
Xiao, H,
Spratt, DE,
Sangoi, AR,
Shao, L,
Betz, BL,
Brown, N,
Tickoo, SK,
McKenney, JK,
Argani, P,
Gupta, S,
Reuter, VE,
Chinnaiyan, AM,
Dhanasekaran, SM,
Mehra, R,
Mod Pathol, 2021 Aug; DOI:10.1038/s41379-021-00803-z Acupressure for cancer-fatigue in ovarian cancer survivor (The AcuOva Study): A community-based clinical trial study protocol examining the impact of self-acupressure on persistent cancer related fatigue in ovarian cancer survivors
Zick, SM,
Kruger, G,
Harte, S,
Sen, A,
Harris, RE,
Pearce, CL,
Contemp Clin Trials, 2021 Aug; DOI:10.1016/j.cct.2021.106477 Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma
Chaudhary, S,
Brown, N,
Song, JY,
Yang, L,
Skrabek, P,
Nasr, MR,
Wong, JT,
Bedell, V,
Murata-Collins, J,
Kochan, L,
Li, J,
Zhang, W,
Chan, WC,
Weisenburger, DD,
Perry, AM,
Hum Pathol, 2021 Aug; DOI:10.1016/j.humpath.2021.04.014 An extrauterine extensively metastatic epithelioid trophoblastic tumor responsive to pembrolizumab
Bell, SG,
Uppal, S,
Sakala, MD,
Sciallis, AP,
Rolston, A,
Gynecol Oncol Rep, 2021 Aug; DOI:10.1016/j.gore.2021.100819 Characterization and in vitro cytotoxic assessment of zinc oxide nano-particles in human epidermoid carcinoma cells
Khan, MF,
Siddiqui, S,
Zia, Q,
Ahmad, E,
Jafri, A,
Arshad, M,
Jamal, A,
Alam, MM,
Banawas, S,
Alshehri, BA,
Baazeem, A,
Althobaiti, F,
Ansari, AH,
Mohammadi, AA,
Journal of Environmental Chemical Engineering, 2021 Aug; DOI:10.1016/j.jece.2021.105636 Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes
Esagian, SM,
Khaki, AR,
Diamantopoulos, LN,
Carril-Ajuria, L,
Castellano, D,
De Kouchkovsky, I,
Park, JJ,
Alva, A,
Bilen, MA,
Stewart, TF,
McKay, RR,
Santos, VS,
Agarwal, N,
Jain, J,
Zakharia, Y,
Morales-Barrera, R,
Devitt, ME,
Nelson, A,
Hoimes, CJ,
Shreck, E,
Gartrell, BA,
Sankin, A,
Tripathi, A,
Zakopoulou, R,
Bamias, A,
Rodriguez-Vida, A,
Drakaki, A,
Liu, S,
Kumar, V,
Lythgoe, MP,
Pinato, DJ,
Murgic, J,
Fröbe, A,
Joshi, M,
Isaacsson Velho, P,
Hahn, N,
Alonso Buznego, L,
Duran, I,
Moses, M,
Barata, P,
Galsky, MD,
Sonpavde, G,
Yu, EY,
Msaouel, P,
Koshkin, VS,
Grivas, P,
BJU Int, 2021 Aug; DOI:10.1111/bju.15324 Discovery of M-1121 as an Orally Active Covalent Inhibitor of Menin-MLL Interaction Capable of Achieving Complete and Long-Lasting Tumor Regression
Zhang, M,
Aguilar, A,
Xu, S,
Huang, L,
Chinnaswamy, K,
Sleger, T,
Wang, B,
Gross, S,
Nicolay, BN,
Ronseaux, S,
Harvey, K,
Wang, Y,
McEachern, D,
Kirchhoff, PD,
Liu, Z,
Stuckey, J,
Tron, AE,
Liu, T,
Wang, S,
J Med Chem, 2021 Jul; DOI:10.1021/acs.jmedchem.1c00789 The dual distinct role of telomerase in repression of senescence and myofibroblast differentiation
Harada, M,
Hu, B,
Lu, J,
Wang, J,
Rinke, AE,
Wu, Z,
Liu, T,
Phan, SH,
Aging (Albany NY), 2021 Jul; DOI:10.18632/aging.203246 Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation
Metzger, ML,
Link, MP,
Billett, AL,
Flerlage, J,
Lucas, JT,
Mandrell, BN,
Ehrhardt, MJ,
Bhakta, N,
Yock, TI,
Friedmann, AM,
de Alarcon, P,
Luna-Fineman, S,
Larsen, E,
Kaste, SC,
Shulkin, B,
Lu, Z,
Li, C,
Hiniker, SM,
Donaldson, SS,
Hudson, MM,
Krasin, MJ,
J Clin Oncol, 2021 Jul; DOI:10.1200/JCO.20.03286 Vismodegib for preservation of visual function in patients with advanced periocular basal cell carcinoma: The VISORB trial
Kahana, A,
Unsworth, SP,
Andrews, CA,
Chan, MP,
Bresler, SC,
Bichakjian, CK,
Durham, AB,
Demirci, H,
Elner, VM,
Nelson, CC,
Kim, DS,
Joseph, SS,
Swiecicki, PL,
Worden, FP,
Oncologist, 2021 Jul; DOI:10.1002/onco.13820 Immunophenotypic switch in cutaneous T-cell lymphoma: A series of three cases and review of the literature
Bitar, C,
Hile, G,
Brown, NA,
Fullen, DR,
Lowe, L,
Tejasvi, T,
Wilcox, RA,
Harms, PW,
Chan, MP,
Bresler, SC,
Hristov, AC,
J Cutan Pathol, 2021 Jul; DOI:10.1111/cup.14026 Assessment of MR Imaging and CT in Differentiating Hereditary and Nonhereditary Paragangliomas
Ota, Y,
Naganawa, S,
Kurokawa, R,
Bapuraj, JR,
Capizzano, A,
Kim, J,
Moritani, T,
Srinivasan, A,
AJNR Am J Neuroradiol, 2021 Jul; DOI:10.3174/ajnr.A7166 Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors
Ma, VT,
Su, CT,
Hu, M,
Taylor, JMG,
Daignault-Newton, S,
Kellezi, O,
Dahl, MN,
Shah, MA,
Erickson, S,
Lora, J,
Hamasha, R,
Ali, A,
Yancey, S,
Kiros, L,
Balicki, HM,
Winfield, DC,
Green, MD,
Alva, AS,
Urol Oncol, 2021 Jul; DOI:10.1016/j.urolonc.2021.01.006 